From October 1, 2021 to December 31, 2021, the company has repurchased 4,307,000 shares, representing 0.79% for CNY 70 million. With this, the company has completed the repurchase of 6,877,000 shares, representing 1.26% for CNY 105.09 million under the buyback announced on August 4, 2021.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.8 CNY | +3.77% |
|
-1.46% | -5.98% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-5.98% | 652M | |
+56.89% | 823B | |
+39.66% | 627B | |
-6.55% | 353B | |
+15.99% | 320B | |
+7.92% | 295B | |
+14.04% | 239B | |
+14.41% | 220B | |
-0.37% | 219B | |
+7.94% | 167B |
- Stock Market
- Equities
- 300497 Stock
- News Jiangxi Fushine Pharmaceutical Co., Ltd.
- Tranche Update on Jiangxi Fushine Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on August 4, 2021.